Researchers from the University of Pittsburg School of Medicine are utilizing mesenchymal stem cells [MSCs] to develop a treatment for Idiopathic Pulmonary Fibrosis (IPF). MSCs possess valuable properties that make them particularly suitable for potential treatments – chief amongst them are; their plasticity [ability to differentiate into a particular tissue type], their anti-inflammatory capabilities and, their immunomodulatory properties. Currently, there are five Phase 1 clinical trials registered utilizing MSCs to treat IPF.
MSCs are the type of stem cell found in dental pulp. By banking their own valuable stem cells, families can ensure that they will have access to emerging regenerative therapies. To learn more about banking stem cells, please visit StemSave or call 877-783- 6728 (877-StemSave) today.
The Future of Regenerative Medicine is Now™
To view the full article, click here.